Etiology, pathogenesis, and morphology of juvenile hemangiomas


Cite item

Full Text

Abstract

Juvenile hemangiomas are benign vascular tumors diagnosed in 3-10% newborns and infants and emerging as a result of malformation of blood vessels under conditions of angiogenesis dysregulation. Mechanisms and probable causes of their emergence are detected and the morphology of hemangioma evolution is described. None of the known hypotheses alone describes at full length the mechanisms of these tumors initiation and regression, that necessitates analysis of all available published data.

About the authors

Vladislav V. Dubensky

Tver State Medical Academy

Email: DubenskyVV@tvgma.ru
MD, PhD, docent 170100, Tver, Russia

References

  1. Jacobs A.H., Walton R.G. The incidence of birthmarks in the neonate. Pediatrics. 1976; 58(2): 218-22.
  2. Hoornweg M.J., Smeulders M.J., van der Horst C.M. Prevalence and characteristics of haemangiomas in young children. Ned. Tijdschr. Geneeskd. 2005; 149(44): 2455-8.
  3. Kilcline C., Frieden I.J. Infantile hemangiomas: how common are they? A systematic review of the medical literature. Pediatr. Dermatol. 2008; 25(2): 168-73. doi: 10.1111/j.1525-1470.2008.00626.x.
  4. Дубенский В.В. Клинико-функциональные особенности ювенильных гемангиом. Современные проблемы дерматовенерологии, иммунологии, косметологии. 2013; 5: 15-24. [Dubenskiy V.V. Clinico-funktionale features of juvenile hemangiomas. Sovremennye problemy dermatovenerologii, immunologii, kosmetologii. 2013; 8: 15-24]
  5. Leaute-Labreze C., Prey S., Ezzedine K. Infantile haemangioma: Part I. Pathophysiology, epidemiology, clinical features, life cycle and associated structural abnormalities. J. Eur. Acad. Dermatol. Venereol. 2011; 25(11): 1245-53. doi: 10.1111/j.1468-3083.2011.04102.x.
  6. Haggstrom A.N., Drolet B.A., Baselga E., Chamlin S.L., Garzon M.C., Horii K.A., et al. Prospective study of infantile hemangiomas: clinical characteristics predicting complications and treatment. Pediatrics. 2006; 118(3): 882-7.
  7. Drolet B.A., Swanson E.A., Frieden I.J.; Hemangioma Investigator Group. Infantile hemangiomas: an emerging health issue linked to an increased rate of low birth weight infants. J. Pediatr. 2008; 153(5): 712-5. doi: 10.1016/j.jpeds.2008.05.043.
  8. Bauland C.G., Smit J.M., Bartelink L.R., Zondervan H.A., Spauwen P.H. Hemangioma in the newborn: increased incidence after chorionic villus sampling. Prenat. Diagn. 2010; 30(10): 913-7. doi: 10.1002/pd.2562.
  9. Bruckner A.L., Frieden I.J. Hemangiomas of infancy. J. Am. Acad. Dermatol. 2003; 48(4): 477-93.
  10. Enjolras O. Vascular stains, malformations, and tumors. In: Eichenfield L.F., Frieden I.J., Esterly N.B., eds. Neonatal dermatology. Philadelphia: Saunders Elsevier; 2008.
  11. Garzon M.C., Enjolras O., Frieden I.J. Vascular tumors and vascular malformations: evidence for an association. J. Am. Acad. Dermatol. 2000; 42(2,Pt 1): 275-9.
  12. Colonna V., Resta L., Napoli A., Bonifazi E. Placental hypoxia and neonatal haemangioma: clinical and histological observations. Br. J. Dermatol. 2010; 162(1): 208-9. doi: 10.1111/j.1365-2133.2009.09493.x.
  13. North P.E., Waner M., Mizeracki A., Mrak R.E., Nicholas R., Kincannon J., et al. A unique microvascular phenotype shared by juvenile hemangiomas and human placenta. Arch. Dermatol. 2001; 137(5): 559-70.
  14. North P.E., Waner M., Brodsky M.C. Are infantile hemangiomas of placental origin? Ophthalmology. 2002; 109(4): 633-4.
  15. Hoeger P.H., Maerker J.M., Kienast A.K., Syed S.B., Harper J.I. Neonatal haemangiomatosis associated with placental chorioangiomas: report of three cases and review of the literature. Clin. Exp. Dermatol. 2009; 34(5): e78-80.doi: 10.1111/j.1365-2230.2009.03221.x.
  16. Boye E., Yu Y., Paranya G., Mulliken J.B., Olsen B.R., Bischoff J. Clonality and altered behavior of endothelial cells from hemangiomas. J. Clin. Invest. 2001; 107(6): 745-52.
  17. Marchuk D.A. Pathogenesis of hemangioma. J. Clin. Invest. 2001; 107(6): 665-6.
  18. Talks K.L., Harris A.L. Current status of antiangiogenic factors. Br. J. Haematol. 2000; 109(3): 477-89.
  19. Berg J.N., Walter J.W., Thisanagayam U., Evans M., Blei F., Waner M., et al. Evidence for loss of heterozygosity of 5q in sporadic haemangiomas: are somatic mutations involved in haemangioma formation? J. Clin. Pathol. 2001; 54(3): 249-52.
  20. Yu Y., Flint A.F., Mulliken J.B., Wu J.K., Bischoff J., et al. Endothelial progenitor cells in infantile hemangiomas. Blood. 2004; 103(4): 1373-5.
  21. Ritter M.R., Butschek R.A., Friedlander M., Friedlander S.F. Pathogenesis of infantile haemangioma: new molecular and cellular insights. Expert Rev. Mol. Med. 2007; 9: 1-19.
  22. Sundine M.J., Wirth G.A. Hemangiomas: an overview. Clin. Pediatr. 2007; 46(3): 206-21.
  23. Jinnin M., Ishihara T., Boye E., Olsen B.R. Recent progress in studies of infantile hemangioma. J. Dermatol. 2010; 37(4): 28398. doi: 10.1111/j.1346-8138.2010.00813.x.
  24. Mulliken J.B., Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast. Reconstr. Surg. 1982; 69(3): 412-22.
  25. Khan Z.A., Boscolo E., Picard A., Psutka S., Melero-Martin J.M., Bartch T.C., et al. Multipotential stem cells recapitulate human infantile hemangioma in immunodeficient mice. J. Clin. Invest. 2008; 118(7): 2592-9. doi: 10.1172/JCI33493.
  26. Дубенский В.В. Новое в патогенезе ювенильных гемангиом. Современные проблемы дерматовенерологии, иммунологии, косметологии. 2013; 3: 23-9. [Dubenskiy V.V. New in the pathogenesis of juvenile hemangiomas. Sovremennye problemy dermatovenerologii, immunologii, kosmetologii. 2013; 3: 23-9]
  27. Giatromanolaki A., Arvanitidou V., Hatzimichael A., Simopoulos C., Sivridis E. The HIF-2alpha/VEGF pathway activation in cutaneous capillary hemangiomas. Pathology. 2005; 37(2): 149-51.
  28. Razon M.J., Kraling B.M., Mulliken J.B., Bischoff J. Increased apoptosis coincides with onset of involution in infantile hemangioma. Microcirculation. 1998; 5(2-3): 189-95.
  29. Mulliken J.B., Enjolras O. Congenital hemangiomas and infantile hemangioma: missing links. J. Am. Acad. Dermatol. 2004; 50(6): 875-82.
  30. Leaute-Labreze C., Taieb A. Efficacy of beta-blockers in infantile capillary haemangiomas: the physiopathological significance and therapeutic consequences. Ann. Dermatol. Venereol. 2008; 135(12): 860-2. doi: 10.1016/j.annder.2008.10.006.
  31. Drolet B.A., Frieden I.J. Characteristics of infantile hemangiomas as clues to pathogenesis: does hypoxia connect the dots? Arch. Dermatol. 2010; 146(11): 1295-9. doi: 10.1001/archdermatol.2010.1295.
  32. Chang E.l., Thangarajah H., Hamou C., Gurtner G.C. Hypoxia, hormones, and endothelial progenitor cells in hemangioma. Lymphat. Res. Biol. 2007; 5(4): 237-43. doi: 10.1089/lrb.2007.1014.
  33. Gonzalez-Crussi F., Reyes-Mugica M. Cellular hemangiomas (“hemangioendotheliomas”) in infants: light microscopic, immunohistochemical, and ultrastructural observations. Am. J. Surg. Pathol. 1991; 15(8): 769-78.
  34. Takahashi K., Mulliken J.B., Kozakewich H.P., Rogers R.A., Folkman J., Ezekowitz R.A. Cellular markers that distinguish the phases of hemangioma during infancy and childhood. J. Clin. Invest. 1994; 93(6): 2357-64.
  35. Yu Y., Varughese J., Brown L.F., Mulliken J.B., Bischoff J. Increased Tie2 expression, enhanced response to angiopoietin-1, and dysregulated angiopoietin-2 expression in hemangioma-derived endothelial cells. Am. J. Pathol. 2001; 159(6): 2271-80.
  36. Tan S.T., Velickovic M., Ruger B.M., Davis P.F. Cellular and extracellular markers of hemangioma. Plast. Reconstr. Surg. 2000; 106(3): 529-38.
  37. Itinteang T., Tan S.T., Brasch H., Day D.J. Primitive mesodermal cells with a neural crest stem cell phenotype predominate proliferating infantile haemangioma. J. Clin. Pathol. 2010; 63(9): 771-6. doi: 10.1136/jcp.2010.079368.
  38. Boye E., Yu Y, Paranya G., Mulliken J.B., Olsen B.R., Bischoff J. Clonality and altered behaviour of endothelial cells from hemangiomas. J. Clin. Invest. 2001; 107(6): 745-52.
  39. Yu Y., Fuhr J., Boye E., Gyorffy S., Soker S., Atala A., et al. Mesenchymal stem cells and adipogenesis in hemangioma involution. Stem Cells. 2006; 24(6): 1605-12.

Copyright (c) 2014 Eco-Vector


 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies